Company Filing History:
Years Active: 2021-2025
Title: Innovations of Johannes Gerardus Maria Evers
Introduction
Johannes Gerardus Maria Evers is a notable inventor based in Utrecht, Netherlands. He has made significant contributions to the field of biotechnology, particularly in the development of engineered antibodies. With a total of four patents to his name, Evers has been at the forefront of innovative solutions for treating various disorders, including cancer.
Latest Patents
Evers' latest patents include groundbreaking work on engineered IgA antibodies. These antibodies feature a modified IgA2 heavy chain constant region, which enhances their effectiveness in pharmaceutical compositions and treatment methods. The engineered antibodies are designed to treat disorders by administering these modified IgA antibodies, which have specific amino acid substitutions or deletions that alter naturally occurring glycosylation sites. Another significant patent involves anti-GD2 antibodies, which are crucial for targeting GD2 positive tumors, particularly neuroblastoma. This invention includes a unique antibody variable domain and constant domains, showcasing Evers' innovative approach to cancer treatment.
Career Highlights
Throughout his career, Evers has worked with prominent organizations such as UMC Utrecht Holding B.V. and Tiga Tx, Inc. His work in these institutions has allowed him to advance his research and contribute to the development of novel therapeutic strategies.
Collaborations
Evers has collaborated with esteemed colleagues, including Jeanette Henrica Wilhelmina Leusen and Geert Jan Van Tetering. These partnerships have fostered a collaborative environment that enhances the research and development of innovative treatments.
Conclusion
Johannes Gerardus Maria Evers is a distinguished inventor whose work in engineered antibodies has the potential to revolutionize cancer treatment. His contributions to biotechnology and collaboration with other experts highlight his commitment to advancing medical science.